ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 834

Implementing Patient-Reported Outcome Measures in Clinical Care: Rheumatologist Perspectives on Opportunities and Challenges

Shanthini Kasturi1, John Wong 1, Lisa Mandl 2, Timothy McAlindon 3 and Amy LeClair 1, 1Tufts Medical Center, Boston, 2Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY, 3Tufts Medical Center, Boston, MA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: patient outcomes, patient-reported outcome measures, quality of life and quality of care, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S076: Patient Outcomes, Preferences, & Attitudes I: Patient Reported Outcomes (833–838)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: There is growing interest in the implementation of patient-reported outcome measures (PROMs) in clinical rheumatology to promote patient-centered care and to meet the mandates of value-based health care initiatives. While studies suggest that patients support the routine measurement of patient-reported outcomes in clinical care, the views of rheumatologists are unknown. Understanding rheumatologists’ perspectives on the potential utility and challenges of using PROMs at the point of care is critical to the successful clinical implementation of PROMs. The objective of this study was to investigate rheumatologists’ views on the benefits of and barriers to utilizing PROMs in clinical care, with a specific focus on patients with systemic lupus erythematosus (SLE).

Methods: Structured interviews were conducted with academically affiliated clinical rheumatologists. Interviews were audio-recorded and transcribed verbatim. De-identified transcripts were uploaded into DedooseTM Version 8.2.14 web application for qualitative data analysis. Two authors (SK and AL) reviewed a subset of transcripts to construct a preliminary codebook which was iteratively updated to include emergent themes as additional transcripts were coded. The final codebook was applied using a comparison and consensus approach. Thematic analysis was used to identify the main benefits and barriers of the use of PROMs in clinical care.

Results: Interviewees consisted of 15 attending rheumatologists affiliated with two academic medical centers in two states, and included 8 women (53%) and 7 men (47%). Subjects reported a median of 15 years in practice (range 5 to 43), with 53% reporting a specific interest in SLE. Rheumatologists identified several uses and benefits of implementing PROMs in clinical care (Table 1), including contributing to the clinical impression by providing the patient perspective, and promoting agenda setting by uncovering “the unspoken questions.” Interviewees noted PROMs could support treatment planning by enabling longitudinal tracking, identifying avenues for intervention, and providing a mechanism for asynchronous care and population management. They noted significant benefits of PROMs in building patient-physician relationships and facilitating patient engagement. However, they also identified several barriers to integrating PROMs in clinical care (Table 2), highlighting physician buy-in and culture change as significant challenges beyond logistical considerations. They further underscored the lack of effective interventions and resources for addressing the domains of most interest to patients.

Conclusion: Rheumatologists identified multiple mechanisms through which PROMs could augment the care of SLE, but also noted several obstacles to implementation in clinical settings, questioning the added value of PROMs and the limited availability of interventions to improve patient-centered outcomes. Programs seeking to successfully integrate PROMs to enhance patient-centered care and meet quality benchmarks must prioritize physician buy-in and training, and provide resources to address the outcomes that are measured.


Table 1 5-31-19

Table 1


Table 2 5-31-19

Table 2


Disclosure: S. Kasturi, None; J. Wong, None; L. Mandl, Annals of Internal Medicine, 3, Annals of Internal Medicine- Associate Editor, 3, UpToDate, 7, Wolters Kluwer - Author at UptoDate, 7, Wolters Kluwer - Author at UpToDate, 7, Wolters Kluwer- Author at UpToDate, 7; T. McAlindon, None; A. LeClair, None.

To cite this abstract in AMA style:

Kasturi S, Wong J, Mandl L, McAlindon T, LeClair A. Implementing Patient-Reported Outcome Measures in Clinical Care: Rheumatologist Perspectives on Opportunities and Challenges [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/implementing-patient-reported-outcome-measures-in-clinical-care-rheumatologist-perspectives-on-opportunities-and-challenges/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementing-patient-reported-outcome-measures-in-clinical-care-rheumatologist-perspectives-on-opportunities-and-challenges/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology